3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
6
Head & Neck
2
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Colorectal Neoplasms
315
Pancreatic Neoplasms
186
Carcinoma, Hepatocellular
116
Stomach Neoplasms
110
Colonic Neoplasms
84
Esophageal Neoplasms
80
Carcinoma, Non-Small-Cell Lung
80
Breast Neoplasms
78
Rectal Neoplasms
75
Ovarian Neoplasms
62
Neoplasm Metastasis
59
Lung Neoplasms
58
Neoplasms
54
Cholangiocarcinoma
53
Melanoma
45
Liver Neoplasms
45
Gastrointestinal Neoplasms
43
Prostatic Neoplasms
42
Biliary Tract Neoplasms
37
Endometrial Neoplasms
33
Squamous Cell Carcinoma of Head and Neck
31
Sarcoma
29
Carcinoma, Renal Cell
29
Esophageal Squamous Cell Carcinoma
27
Uterine Cervical Neoplasms
26
Adenocarcinoma Of Esophagus
24
Head and Neck Neoplasms
23
Urinary Bladder Neoplasms
22
Small Cell Lung Carcinoma
20
Gastrointestinal Stromal Tumors
17
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Gastrointestinal
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled